Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
19
pubmed:dateCreated
2008-9-23
pubmed:abstractText
In plants, as in mammals, mutations in SNF2-like DNA helicases/ATPases were shown to affect not only chromatin structure but also global methylation patterns, suggesting a potential functional link between chromatin structure and epigenetic marks. The SNF2-like ATPase containing nucleosome remodeling and deacetylase corepressor complex (NuRD) is involved in gene transcriptional repression and chromatin remodeling. We have previously shown that the leukemogenic protein PML-RARa represses target genes through recruitment of DNA methytransferases and Polycomb complex. Here, we demonstrate a direct role of the NuRD complex in aberrant gene repression and transmission of epigenetic repressive marks in acute promyelocytic leukemia (APL). We show that PML-RARa binds and recruits NuRD to target genes, including to the tumor-suppressor gene RARbeta2. In turn, the NuRD complex facilitates Polycomb binding and histone methylation at lysine 27. Retinoic acid treatment, which is often used for patients at the early phase of the disease, reduced the promoter occupancy of the NuRD complex. Knockdown of the NuRD complex in leukemic cells not only prevented histone deacetylation and chromatin compaction but also impaired DNA and histone methylation, as well as stable silencing, thus favoring cellular differentiation. These results unveil an important role for NuRD in the establishment of altered epigenetic marks in APL, demonstrating an essential link between chromatin structure and epigenetics in leukemogenesis that could be exploited for therapeutic intervention.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18644863-10204490, http://linkedlifedata.com/resource/pubmed/commentcorrection/18644863-10742099, http://linkedlifedata.com/resource/pubmed/commentcorrection/18644863-11099047, http://linkedlifedata.com/resource/pubmed/commentcorrection/18644863-11230151, http://linkedlifedata.com/resource/pubmed/commentcorrection/18644863-11257111, http://linkedlifedata.com/resource/pubmed/commentcorrection/18644863-11259576, http://linkedlifedata.com/resource/pubmed/commentcorrection/18644863-11274056, http://linkedlifedata.com/resource/pubmed/commentcorrection/18644863-11297506, http://linkedlifedata.com/resource/pubmed/commentcorrection/18644863-11711429, http://linkedlifedata.com/resource/pubmed/commentcorrection/18644863-11777905, http://linkedlifedata.com/resource/pubmed/commentcorrection/18644863-11834837, http://linkedlifedata.com/resource/pubmed/commentcorrection/18644863-11910072, http://linkedlifedata.com/resource/pubmed/commentcorrection/18644863-11948614, http://linkedlifedata.com/resource/pubmed/commentcorrection/18644863-12351412, http://linkedlifedata.com/resource/pubmed/commentcorrection/18644863-14675539, http://linkedlifedata.com/resource/pubmed/commentcorrection/18644863-15454082, http://linkedlifedata.com/resource/pubmed/commentcorrection/18644863-15616584, http://linkedlifedata.com/resource/pubmed/commentcorrection/18644863-15735696, http://linkedlifedata.com/resource/pubmed/commentcorrection/18644863-15809276, http://linkedlifedata.com/resource/pubmed/commentcorrection/18644863-15870198, http://linkedlifedata.com/resource/pubmed/commentcorrection/18644863-16322236, http://linkedlifedata.com/resource/pubmed/commentcorrection/18644863-16432238, http://linkedlifedata.com/resource/pubmed/commentcorrection/18644863-16462733, http://linkedlifedata.com/resource/pubmed/commentcorrection/18644863-17146439, http://linkedlifedata.com/resource/pubmed/commentcorrection/18644863-17244680, http://linkedlifedata.com/resource/pubmed/commentcorrection/18644863-17560329, http://linkedlifedata.com/resource/pubmed/commentcorrection/18644863-17560333, http://linkedlifedata.com/resource/pubmed/commentcorrection/18644863-17694084, http://linkedlifedata.com/resource/pubmed/commentcorrection/18644863-2805068, http://linkedlifedata.com/resource/pubmed/commentcorrection/18644863-7697714, http://linkedlifedata.com/resource/pubmed/commentcorrection/18644863-8316832, http://linkedlifedata.com/resource/pubmed/commentcorrection/18644863-9486654, http://linkedlifedata.com/resource/pubmed/commentcorrection/18644863-9486655, http://linkedlifedata.com/resource/pubmed/commentcorrection/18644863-9663395, http://linkedlifedata.com/resource/pubmed/commentcorrection/18644863-9759497, http://linkedlifedata.com/resource/pubmed/commentcorrection/18644863-9790534, http://linkedlifedata.com/resource/pubmed/commentcorrection/18644863-9804427, http://linkedlifedata.com/resource/pubmed/commentcorrection/18644863-9836641, http://linkedlifedata.com/resource/pubmed/commentcorrection/18644863-9885572
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1098-5549
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
28
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5912-23
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
MBD3, a component of the NuRD complex, facilitates chromatin alteration and deposition of epigenetic marks.
pubmed:affiliation
Centre de Regulacio Genomica, Universitat Pompeu Fabra, Barcelona, Spain.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't